22 completed, 13 unknown, 9 terminated, 3 not yet recruiting. 54 Phase 3, 21 Phase 2.
Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol Propranolol, Psychotherapy - Post-Traumatic Stress Disorder, PTSD | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 70 | 2026-12-01 | 2026-11-06 |
| Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind Study Propranolol + Placebo - Traumatic Brain Injury (TBI) Patients | Phase 3 | Recruiting | Fundació d'investigació Sanitària de les Illes Balears | 536 | 2026-06-01 | 2026-10-27 |
| Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI propranolol, normal saline IV - Traumatic Brain Injury (TBI) Patients, Intracranial Pressure | Phase 3 | Not yet recruiting | Tanta University | 60 | 2025-09-20 | 2025-03-11 |
| Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine Propranolol 80 mg, Magnesium 400Mg - Migraine, Nutraceuticals | Phase 3 | Not yet recruiting | Fayoum University | 100 | 2025-08-20 | 2025-08-29 |
| Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma propranolol - Infantile Hemangioma | Phase 2 / Phase 3 | Active not recruiting | West China Hospital | 34 | 2025-02-01 | 2026-11-16 |
| Zonisamide Versus Propranolol in Migraine Zonisamide 50 MG, Propranolol - Migraine | Phase 3 | Unknown | Kafrelsheikh University | 600 | 2024-03-29 | 2024-04-23 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) Propranolol Hydrochloride, control group - Stroke, Vascular Accident | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 168 | 2023-02-21 | 2025-07-14 |
| Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol Propranolol Oral Product, Placebo, memory reactivation - PTSD | Phase 3 | Recruiting | University Hospital, Toulouse | 92 | 2023-02-01 | 2023-08-28 |
| Role of Combined Therapy of Propranolol and Gabapentin in Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury Propranolol , gabapentin - Traumatic Brain Injury | Phase 3 | Unknown | Zagazig University | 90 | 2022-12-01 | 2023-06-13 |
| Lacosamide Versus Propranolol in Migraine Lacosamide tablet, Propranolol - Migraine Disorders | Phase 3 | Completed | Kafrelsheikh University | 600 | 2022-06-01 | 2024-05-01 |
| Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation Propranolol Hydrochloride - Mechanical Ventilation, Sedation | Phase 3 | Completed | Ottawa Hospital Research Institute | 72 | 2021-01-08 | 2022-12-05 |
| Propranolol Rescue of Prolonged Labor Propranolol Hydrochloride, Saline - Pregnancy, Prolonged | Phase 3 | Terminated | Lisa Levine | 164 | 2020-07-14 | 2023-08-23 |
| Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension Propranolol, Carvedilol, Rosuvastatin - Cirrhosis, Portal Hypertension | Phase 2 / Phase 3 | Unknown | Universidade Federal do Rio de Janeiro | 80 | 2019-01-25 | 2019-05-14 |
| Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial Combined Intravitreal bevacizumab and propranolol, Intravitreal bevacizumab - Age Related Macular Degeneration | Phase 2 / Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 40 | 2018-09-01 | 2018-08-01 |
| Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis nonselective beta blocker, cardio-selective beta blocker group, alendronate sodium - Beta Blocker Toxicity | Phase 3 | Recruiting | Sherief Abd-Elsalam | 50 | 2017-10-01 | 2021-01-12 |
| Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia Propranolol Hydrochloride, Placebo Oral Tablet - Tardive Dyskinesia | Phase 2 / Phase 3 | Withdrawn | Emory University | 2017-09-18 | 2019-02-26 | |
| MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients Propranolol, Placebo - Melanoma | Phase 2 / Phase 3 | Unknown | Azienda Sanitaria di Firenze | 546 | 2017-06-01 | 2016-11-15 |
| Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism Cholestyramine Powder 4g, Prednisolone, Standard treatment - Hyperthyroidism, Graves Disease | Phase 3 | Unknown | Clinical Research Centre, Malaysia | 135 | 2017-05-11 | 2017-10-05 |
| Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas oral propranolol, oral atenolol - Infantile Hemangioma | Phase 3 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 60 | 2017-03-24 | 2018-08-28 |
| Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis Proton-pump inhibitor, Propranolol+Proton-pump inhibitor - Liver Cirrhosis, Peptic Ulcer | Phase 2 / Phase 3 | Terminated | Taipei Veterans General Hospital, Taiwan | 10 | 2016-12-26 | 2020-06-23 |
Showing 20 of 54. Sign in to see all of them.
Burns (5) · Hemangioma, Capillary (5) · Hypertension, Portal (5) · Liver Cirrhosis (5) · Fibrosis (4) · Migraine Disorders (4) · Stress Disorders, Post-Traumatic (4) · Brain Injuries, Traumatic (3) · Hemangioma (3) · Cardiovascular Diseases (2) · Coronary Disease (2) · Esophageal and Gastric Varices (2) · Heart Diseases (2) · Migraine with Aura (2) · Migraine without Aura (2)
The University of Texas Medical Branch, Galveston (5) · Govind Ballabh Pant Hospital (2) · Kafrelsheikh University (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · University Hospital, Toulouse (2) · West China Hospital (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ain Shams Maternity Hospital (1) · Anne Lindblad (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Sanitaria di Firenze (1) · Beijing Tiantan Hospital (1) · Clinical Research Centre, Malaysia (1) · Douglas Mental Health University Institute (1)
United States (12) · Canada (6) · Egypt (6) · France (5) · China (4) · India (4) · Italy (3) · Germany (2) · Netherlands (2) · Spain (2) · Australia (1) · Belgium (1) · Brazil (1) · Czechia (1) · Denmark (1)
David N Herndon, MD (4) · A. Eden Evins, MD, MPH (1) · Allan Barker (1) · Allan Jaffee (1) · Charles Laubach (1) · Charles-Siegfried Peretti, MD, PhD (1) · Christine B Sethna, MD, EdM (1) · Christine Labreze, MD (1) · Christopher Hartnick, MD (1) · David Dodick, MD (1) · David N. Herndon, MD (1) · David Richardson (1) · Davide D'Amico, prof, MD (1)
PMID 11914403, PMID 12807523, PMID 22606232, PMID 15316798, PMID 18791359, PMID 19240154, PMID 19734776, PMID 20395554, PMID 20547163, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21789167, PMID 22401315, PMID 22463890, PMID 22895351, PMID 22962431, PMID 23031335, PMID 23150682, PMID 23303450, PMID 23511841, PMID 24009246, PMID 24050955, PMID 24054431, PMID 24298851, PMID 24335848, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25693013, PMID 25807408, PMID 26607848, PMID 27171844, PMID 27433905, PMID 28240622, PMID 33856430, PMID 34747977, PMID 35672572, PMID 36031005, PMID 36656551, PMID 37290102, PMID 38767196, PMID 39082471, PMID 39982178, PMID 41863672, PMID 42088573, PMID 42104241, PMID 8984084
2008 (2), 2025 (2), P50GM060338 (2), R01GM056687 (1)